Newmont vs. SSR Mining: Which Gold Stock Is a Better Buy in 2026?

Newmont posted FY2025 sales of $22.7 billion, net income of $7.1 billion, and $7.3 billion of free cash flow, while SSR Mining reported revenue up 66.5% to nearly $1.7 billion and net income of about $402.7 million versus a $261.3 million loss in 2024. SSR also disclosed a planned $1.5 billion sale of its Copler mine stake, which should de-risk the portfolio and support buybacks, dividends, or expansion, though it retains exposure to labor, Argentina, and concentration risks. Overall, the article is constructive on both miners but slightly favors SSR Mining for 2026 due to higher growth and the upcoming asset sale.

Analysis

Newmont is the cleaner balance-sheet compounder, but the market is paying for that stability with lower optionality. The more interesting second-order dynamic is that a large, diversified producer with strong free cash flow can use the cycle to internalize optionality via buybacks, mine optimization, and distressed asset acquisition, which tends to matter most over a 12-24 month horizon rather than on the next quarterly print.

SSR Mining’s setup is more asymmetric than the headline multiple suggests. The pending Turkey exit is not just a de-risking event; it converts a litigation/operational overhang into deployable capital, which can reset capital returns and re-rate the name if management signals disciplined allocation within 1-2 quarters of closing. That said, the stock likely trades as a “show-me” story until the cash is on the balance sheet and reinvestment or buyback capacity is clearly visible.

Consensus appears to underweight how much leverage both names have to gold, but in different ways: Newmont is a high-beta cash generator, while SSRM is a capital structure story disguised as a growth story. If gold stalls, SSRM’s lower valuation may not protect it as much as expected because concentrated asset risk and jurisdictional exposure can dominate; if gold rises, SSRM should outperform on multiple expansion plus operating leverage, with the move potentially front-running the actual asset sale close.

The key risk is timeline slippage. Any delay in the Copler divestiture pushes the rerating catalyst out by months and keeps legal/operational noise attached to the name, while a strong gold pullback would favor Newmont’s durability and dividend/buyback support. The better contrarian read is that Newmont may be the more underappreciated long-duration hold, but SSRM is the better tactical trade if one can tolerate event risk and wait for the cash catalyst to crystallize.

Key Decisions for Investors

• Long SSRM into the Copler sale window (1-2 quarters): favorable asymmetry if the $1.5B cash proceeds close on time; risk is headline/timeline slippage, so size smaller than a core position.
• Pair trade: long SSRM / short NEM for a 3-6 month catalyst window. This captures event-driven rerating in SSRM while hedging broader gold beta; exit if the sale is delayed or if SSRM starts funding low-return growth.
• Use NEM as the core 12-24 month gold exposure rather than a tactical trade. The tradeoff is lower upside, but downside is better cushioned if gold corrects or litigation/compliance noise rises.
• If implementing options, buy SSRM call spreads into confirmation of sale progress rather than chasing common. The thesis needs a discrete catalyst, so defined-risk upside is preferable to outright equity exposure.
• Avoid a naked short on NEM; if bearish on gold, short the metal proxy or use a miner basket hedge instead. NEM’s capital returns and balance-sheet quality make it difficult to break even on a company-specific short absent a sharp commodity drawdown.